SelectQuote Inc

Aktienanalyse zu SelectQuote Inc (SLQT)

$0.481

+0.112 (+23.28%)Zum Schluss

Loading chart…
Hoch
0.530
Eröffnung
0.411
Volumengewichteter Durchschnittskurs
0.47
Volumen
2.75M
Marktkap.
463.49M
Tief
0.400
Umsatz
1.29M
EV/EBITDA, TTM
3.10

SelectQuote, Inc. provides a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. The Company has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote’s Senior division sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other ancillary senior health insurance related products. SelectQuote Healthcare Services comprises SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with healthcare services that fit each member's healthcare needs. SelectQuote’s Auto & Home division primarily sells non-commercial auto and home, property and casualty insurance products. SelectQuote’s Life division sells term life, final expenses, and other ancillary products. SelectRx is a Patient-Centered Pharmacy Home (PCPH) accredited pharmacy.

KI-Analyse of SelectQuote Inc (SLQT)

Kaufen

SelectQuote Inc (SLQT) appears to be a good buy right now due to its recent price momentum and favorable valuation metrics. The current price is $0.402, which is significantly below its 52-week high of $2.17, indicating potential for recovery. The stock has shown a 5-day change of +22.90%, reflecting strong short-term performance. Additionally, the forward P/E ratio is 66.67, suggesting that while the stock is expensive based on earnings, it is trading at a low price-to-sales ratio of 0.0395, indicating it may be undervalued relative to its sales. However, the main risk is the negative earnings per share (EPS) estimate of -0.26 for the upcoming quarter, which could lead to further volatility.

Bewertungskennzahlen

Das aktuelle erwartete KGV von SelectQuote Inc (SLQT) beträgt 19.57, verglichen mit dem 5-Jahres-Durchschnitt von 2.50.

Erwartetes KGV

Fair bewertet
5J-Durchschnitt P/E
2.50
Aktuelles P/E
19.57
Überbewertet
48.70
Unterbewertet
-43.71

Erwartetes EV/EBITDA

Fair bewertet
5J-Durchschnitt EV/EBITDA
1.71
Aktuelles EV/EBITDA
3.10
Überbewertet
54.02
Unterbewertet
-50.59

Erwartetes KUV

Fair bewertet
5J-Durchschnitt P/S
0.29
Aktuelles P/S
0.05
Überbewertet
0.56
Unterbewertet
0.03

Alphio-AI-Kursszenarien für SLQT

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%SLQT

$2.27

Szenariopreis

B

Basis

Basis · 50%SLQT

$2.16

Szenariopreis

B

Bärisch

Bärisch · 25%SLQT

$1.66

Szenariopreis

Whales, die SLQT halten

A

Abrams Bison Investments, L.L.C.

+ HältSLQT

+8.79%

3-Monats-Rendite

Event-Zeitleiste

2026-11-04 (ET)

07:30:00

SelectQuote Reports Q1 Revenue of $280M

07:30:00

Sees FY27 Adjusted EBITDA of $90M-$115M

2026-08-25 (ET)

16:30:00

Major Averages Rise as Chip Stocks Benefit from Nvidia Earnings

12:30:00

Major Averages Slightly Higher, Chip Stocks Benefit from Nvidia Earnings

07:30:00

SelectQuote Q4 Revenue $321.7M, Below Consensus

News

SLQT FAQ – beantwortet von Alphio AI

SelectQuote, Inc. provides a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. The Company has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote’s Senior division sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other ancillary senior health insurance related products. SelectQuote Healthcare Services comprises SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with healthcare services that fit each member's healthcare needs. SelectQuote’s Auto & Home division primarily sells non-commercial auto and home, property and casualty insurance products. SelectQuote’s Life division sells term life, final expenses, and other ancillary products. SelectRx is a Patient-Centered Pharmacy Home (PCPH) accredited pharmacy. It operates in the Financials sector (INSURANCE AGENTS, BROKERS & SERVICE industry).

SelectQuote Inc (SLQT) appears to be a good buy right now due to its recent price momentum and favorable valuation metrics. The current price is $0.402, which is significantly below its 52-week high of $2.17, indicating potential for recovery. The stock has shown a 5-day change of +22.90%, reflecting strong short-term performance. Additionally, the forward P/E ratio is 66.67, suggesting that while the stock is expensive based on earnings, it is trading at a low price-to-sales ratio of 0.0395, indicating it may be undervalued relative to its sales. However, the main risk is the negative earnings per share (EPS) estimate of -0.26 for the upcoming quarter, which could lead to further volatility.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Ähnliche Artikel

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln